Lynparza as maintenance therapy for BRCA-mutated ovarian cancer patients
Ovarian cancer is the 7th most commonly diagnosed cancer in women worldwide1 and the 5th most common cause of...
Oncology
US FDA Approves Midostaurin for Treatment of Acute Myeloid Leukemia
The US FDA approved the use of Rydapt (midostaurin) in combination with chemotherapy for treating recently diagnosed adults with...
Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) by the FDA
Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is not breast cancer but a rare type of T-cell lymphoma that...